Urtica Dioica and Lamium Album Decrease Glycogen Synthase Kinase-3 beta and Increase K-Ras in Diabetic Rats

Mahmood Abedinzade1, Mohammad Rostampour2,3, Ebrahim Mirzajani2,4

  • 1Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.

Abstract

Insights

This study investigated the effects of Urtica Dioica and Lamium Album extracts on diabetic rats. Both herbs helped regulate key proteins and improve blood glucose levels in diabetic models.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Diabetology

Background:

  • Diabetes mellitus is a complex metabolic disorder characterized by hyperglycemia.
  • Key signaling pathways involving K-Ras and GSK-3 beta play a role in glucose homeostasis.
  • Natural compounds are being explored for their potential anti-diabetic effects.

Purpose of the Study:

  • To evaluate the impact of Urtica Dioica and Lamium Album extracts on serum levels of K-Ras and GSK-3 beta in streptozotocin-induced diabetic rats.
  • To assess the efficacy of these herbal extracts in modulating key molecular targets associated with diabetes.

Main Methods:

  • A study involving 32 male Wistar rats, randomly assigned to control and diabetic groups.
  • Diabetes was induced using streptozotocin (60 mg/kg).
  • Treated groups received hydroalcoholic extracts of U. dioica or L. Album (100 mg/kg) daily for 28 days, with measurements of body weight, fasting blood sugar, blood glucose, K-Ras, and GSK-3 beta.

Main Results:

  • Diabetic rats exhibited increased GSK-3 beta and decreased K-Ras levels compared to controls.
  • Both U. dioica and L. Album extracts significantly reduced blood glucose levels.
  • U. dioica extract significantly reduced GSK-3 beta levels, while both extracts increased K-Ras levels in diabetic rats.
  • No significant differences were observed between the two extracts regarding their effects on blood glucose and K-Ras levels.

Conclusions:

  • Urtica Dioica and Lamium Album extracts demonstrate potential in improving blood glucose levels in diabetic rats.
  • These effects appear to be mediated through the regulation of GSK-3 beta and K-Ras pathways.
  • Further research is warranted to fully elucidate the therapeutic potential and mechanisms of these herbs in diabetes management.

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
508
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
477
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
538